Objective: To explore the clinical effect of Sanfeng Tongqiao Diwan in the treatment of allergic rhinitis.

Methods: Allergic rhinitis patients included in this study were randomly divided into control group and study group for 7 days of treatment. The control group was treated with Tongqiao Biyan Pian, while the study group was treated with Sanfeng Tongqiao Diwan.

Results: After 7 days of treatment, the total effective rate of Sanfeng Tongqiao Diwan was 75.76%, which was higher than that of Tongqiao Biyan Pian (65.62%). The scores of visual analogue scale (VAS), symptom relief, Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), and Epworth sleepiness scale (ESS) in both groups were significantly improved before and after treatment ( < 0.05), and the improvement was most significant 24 hours after treatment. The adverse reactions in both groups were low.

Conclusion: Sanfeng Tongqiao Diwan can significantly alleviate the symptoms and improve the quality of life of patients with allergic rhinitis, with less adverse reactions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250434PMC
http://dx.doi.org/10.1155/2022/2916223DOI Listing

Publication Analysis

Top Keywords

sanfeng tongqiao
20
tongqiao diwan
16
allergic rhinitis
12
diwan treatment
8
treatment allergic
8
control group
8
study group
8
days treatment
8
group treated
8
tongqiao biyan
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!